aXichem AB

Stockholm Stock Exchange AXIC-A.ST

aXichem AB Dividend Per Share for the year ending December 31, 2023: USD -0.00

aXichem AB Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • aXichem AB Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
  • aXichem AB Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
  • aXichem AB Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
  • aXichem AB Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: AXIC-A.ST

aXichem AB

CEO Mr. Torsten Helsing
IPO Date March 4, 2011
Location Sweden
Headquarters Södergatan 26
Employees 7
Sector Consumers Staples
Industries
Description

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, an natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was incorporated in 2007 and is based in Malmö, Sweden.

Similar companies

BIM.ST

BIMobject AB

USD 0.53

4.80%

ENZY.ST

Enzymatica AB (publ)

USD 0.13

0.88%

BACTI-B.ST

Bactiguard Holding AB (publ)

USD 3.10

-2.79%

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

ALZ.ST

Alzinova AB (publ)

USD 0.25

-3.82%

StockViz Staff

February 4, 2025

Any question? Send us an email